Paul S. Fishman, MD, PhD

Dr. Fishman is clinical professor of neurology at the University of Maryland School of Medicine. His clinical and research interests include novel therapeutics for Parkinson's disease, Alzheimer's disease and related neurodegenerative diseases, and he has authored more than 100 publications.

Dr. Fishman established UMMC’s program for neurotoxin treatment of movement disorders and is a co-founder of our deep brain stimulation, focused ultrasound surgery, and Alzheimer’s disease programs. He is a member of the Functional Ultrasound (fUS) Center of Excellence at Maryland and is the neurology arm of the team instrumental in FDA approval of fUS technology in the brain for treatment of essential tremor and Parkinson’s disease. Current studies with patients with Parkinson's disease explore this technology as a less invasive alternative to deep brain stimulation and to open the blood-brain barrier for delivery of cellular and molecular therapeutics for neurodegenerative disease.

Dr. Fishman is former chief of neurology for the VA Maryland Health Care System. He is listed in Best Doctors in America. He is former chair of the Parkinson's Disease review group for VA Biomedical Research, past chair of the University of Maryland Institutional Review Board and co-founder of the Medical-Scientific Board of the Alzheimer's Association of Greater Maryland.

Dr. Fishman earned a doctorate in neurobiology from Yale University and his medical degree from Johns Hopkins. He also received training in neurology and cell biology at Columbia-Presbyterian Medical Center.